Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
Is compounding ezetimibe (Zetia) legal? Full regulatory breakdown covering FDA approval history, compounding restrictions under 503A/503B, the current label, and safety data from IMPROVE-IT.
Read clinical reviewA detailed review of ezetimibe (Zetia) adverse event reports in the FDA FAERS database, including musculoskeletal, hepatobiliary, and hypersensitivity signals, with clinical context from IMPROVE-IT and current prescribing guidance.
Read clinical reviewA complete regulatory timeline of ezetimibe (Zetia) from its 2002 FDA approval through IMPROVE-IT outcomes data, generic entry, and current labeling.
Read clinical reviewComplete regulatory overview of ezetimibe (Zetia) worldwide, covering FDA approval history, EMA authorization, label updates, IMPROVE-IT trial impact, generic availability, and ongoing post-market surveillance.
Read clinical reviewA clinical review of ezetimibe's regulatory timeline, patent litigation, ENHANCE controversy, IMPROVE-IT vindication, and the legal battles that shaped generic Zetia access.
Read clinical reviewA detailed comparison of how the FDA and EMA have regulated ezetimibe (Zetia/Ezetrol), from initial approval through post-market surveillance, label updates, and the IMPROVE-IT outcomes data.
Read clinical reviewA complete, physician-reviewed breakdown of every Zetia (ezetimibe) FDA label update from 2020 through 2026, including safety signal changes, new indication data, and what prescribers and patients need to know.
Read clinical reviewA clinical review of ezetimibe (Zetia) regulatory history, FDA approval timeline, current label details, post-market safety surveillance, and next-generation lipid-lowering pipeline candidates.
Read clinical review